Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 6 Influence of naloxone treatment on the plasma levels of cholesterol (A), triglycerides (B), low-density lipoprotein (LDL) (C), and high-density lipoprotein (HDL) (D). Apolipoprotein-E–deficient mice received an IP injection of 10 mg/kg/day (n = 8), 20 mg/kg/day (n = 7), or 25 mg/kg/day (n = 5) naloxone, or phosphate-buffered saline (n = 8) for 10 weeks. The results are expressed as mean values ± SD.
|
